【24h】

Comparative Prospective Study of Two Liver Graft Preservation Solutions: University of Wisconsin and Celsior

机译:威斯康星大学和塞尔西奥大学两种肝移植保存方法的比较前瞻性研究

获取原文
获取原文并翻译 | 示例
           

摘要

University of Wisconsin solution (UWS) is the gold standard for graft preservation. Celsior solution (CS) is a new solution not as yet widely used in liver grafts. The aim of this study was to compare the liver function of transplanted grafts stored in these 2 preservation solutions. The primary endpoints were the rates of primary nonfunction (PNF) and primary dysfunction (PDF). We performed a prospective and pseudorandomized study that included 196 patients (representing 104 and 92 livers preserved in UWS and CS, respectively) at La Fe University Hospital (Valencia, Spain) between March 2003 and May 2005. PNF and PDF rates, liver function laboratory parameters, postoperative bleeding, vascular and biliary complications, and patient and graft survival at 3 years were compared for the 2 groups. The 2 groups were similar in terms of donor variables, recipient variables, and surgical techniques. The PNF rates were 2.2% and 1.9% in the CS and UWS groups, respectively (P = not significant), and the PDF rates were 15.2% and 15.5% in the CS and UWS groups, respectively (P = not significant). There were no significant differences in the laboratory parameters for the 2 groups, except for alanine aminotransferase levels in month 3, which were lower in the CS group (P = 0.01). No significant differences were observed in terms of complications. Three-year patient and graft survival rates were as follows for years 1, 2, and 3: 83%, 80%, and 76% (patient) and 80%, 77%, and 73% (graft) for the UWS group and 83%, 77%, and 70% (patient) and 81%, 73%, and 67% (graft) for the CS group (P = not significant). In conclusion, this study shows that CS is as effective as UWS in liver preservation.
机译:威斯康星大学溶液(UWS)是移植物保存的金标准。 Celsior解决方案(CS)是一种尚未广泛用于肝移植的新解决方案。这项研究的目的是比较两种保存溶液中储存的移植物的肝功能。主要终点为原发性无功能(PNF)和原发性功能障碍(PDF)的发生率。我们在2003年3月至2005年5月间于西班牙拉瓦菲大学医院(西班牙瓦伦西亚)进行了196例患者(分别代表UWS和CS保留的104和92例肝)的前瞻性和伪随机研究。PNF和PDF评分,肝功能实验室比较两组的参数,术后出血,血管和胆道并发症以及3年患者和移植物存活率。两组在供体变量,受体变量和手术技术方面相似。 CS和UWS组的PNF率分别为2.2%和1.9%(P =不显着),而CS和UWS组的PDF率分别为15.2%和15.5%(P =不显着)。除第3个月的丙氨酸转氨酶水平在CS组较低(P = 0.01)外,两组的实验室参数均无显着差异。在并发症方面未观察到显着差异。 UWS组的第1年,第2年和第3年的三年患者和移植物存活率如下:83%,80%和76%(患者),以及80%,77%和73%(移植物), CS组分别为83%,77%和70%(患者)和81%,73%和67%(移植物)(P =不显着)。总之,这项研究表明CS在保肝方面与UWS一样有效。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号